ZEB2 and non-small cell lung carcinoma: To further confirm the influence of ZEB2 on TAM polarization in EGFR-TKI-resistant NSCLC, ZEB2 in both PC9-GR and HCC827-GR cells was knocked down using siRNAs against ZEB2.